Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Pfizer |
---|---|
Information provided by: | Pfizer |
ClinicalTrials.gov Identifier: | NCT00643799 |
To compare the safety and efficacy of celecoxib versus naproxen for the treatment of knee osteoarthritis
Condition | Intervention | Phase |
---|---|---|
Osteoarthritis, Knee |
Drug: Celecoxib Drug: Naproxen Drug: Placebo |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Multicenter, Double-Blind, Double-Dummy Study Comparing the Efficacy and Tolerability of Once Daily Celebrex (Celecoxib) and Naproxen 500 mg Twice Daily in the 6-Month Treatment of Subjects With Osteoarthritis of the Knee |
Enrollment: | 586 |
Study Start Date: | March 2004 |
Study Completion Date: | January 2005 |
Primary Completion Date: | January 2005 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Experimental |
Drug: Celecoxib
200 mg oral capsule once daily for 6 months
|
B: Active Comparator |
Drug: Naproxen
500 mg oral capsule twice daily for 6 months
|
C: Placebo Comparator |
Drug: Placebo
Matched oral placebo for 6 months
|
Ages Eligible for Study: | 40 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study Director: | Pfizer CT.gov Call Center | Pfizer |
Responsible Party: | Pfizer, Inc ( Director, Clinical Trial Disclosure Group ) |
Study ID Numbers: | A3191152 |
Study First Received: | March 18, 2008 |
Last Updated: | April 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00643799 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Anti-Inflammatory Agents Celecoxib Naproxen Osteoarthritis Joint Diseases Cyclooxygenase Inhibitors Rheumatic Diseases Osteoarthritis, Knee |
Musculoskeletal Diseases Analgesics, Non-Narcotic Arthritis Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents |
Anti-Inflammatory Agents Naproxen Celecoxib Molecular Mechanisms of Pharmacological Action Osteoarthritis Joint Diseases Cyclooxygenase Inhibitors Physiological Effects of Drugs Enzyme Inhibitors Rheumatic Diseases Gout Suppressants Pharmacologic Actions |
Osteoarthritis, Knee Musculoskeletal Diseases Analgesics, Non-Narcotic Sensory System Agents Therapeutic Uses Arthritis Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |